All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

REPLY: GDF-15 in Cardiovascular Disease Are We at the Heart of the Energy Balance?

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00085754" target="_blank" >RIV/00023001:_____/25:00085754 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S2213177925004081?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S2213177925004081?via%3Dihub</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jchf.2025.04.007" target="_blank" >10.1016/j.jchf.2025.04.007</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    REPLY: GDF-15 in Cardiovascular Disease Are We at the Heart of the Energy Balance?

  • Original language description

    This letter responds to a comment by Di Vincenzo and colleagues on our study that evaluated the role of growth differentiation factor (GDF)-15 levels in the development of congestive anorexia and weight loss, as well as its association with adverse clinical outcomes in patients with advanced heart failure (HF) and reduced ejection fraction. Our study demonstrated that elevated GDF-15 levels were associated with markers of venous congestion and right ventricular dysfunction. Although we addressed the hypothesis that GDF-15 might function as an energy sensor reflecting metabolic changes in patients with advanced HF, our data do not support this theory. We did not find statistically significant differences in GDF-15 levels between patients with and without metabolic syndrome. We also discussed the possible influence of antidiabetic medications, although our ability to draw conclusions about their influence was limited by the use of a historical cohort. Based on our results, we hypothesize that GDF-15 may share common mechanisms across different clinical conditions, with right ventricular dysfunction and splanchnic congestion being the most likely factors in advanced HF. Our study suggests that hepatic congestion could be a primary source of GDF-15 in this context, although the mechanisms linking hemodynamic congestion to elevated GDF-15 remain incompletely understood.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    JACC. Heart failure

  • ISSN

    2213-1779

  • e-ISSN

    2213-1787

  • Volume of the periodical

    13

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    2

  • Pages from-to

    1-2

  • UT code for WoS article

    001533829800005

  • EID of the result in the Scopus database

    2-s2.0-105008792711